| 711398 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Influence of DM-sensitivity on immunogenicity of MHC class II restricted antigens |
2021-07-01 |
10.1136/jitc-2021-002401 |
Bernhardt Anna Luise, Zeun Julia, Marecek Miriam, Reimann Hannah, Kretschmann Sascha, Bausenwein Judith, van der Meijden Edith D, Karg Margarete M, Haug Tabea, Meintker Lisa, Lutzny-Geier Gloria, Mackensen Andreas, Kremer Anita N |
| 711397 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Identification of neoantigen-reactive T lymphocytes in the peripheral blood of a patient with glioblastoma |
2021-07-01 |
10.1136/jitc-2021-002882 |
Leko Vid, Cafri Gal, Yossef Rami, Paria Biman, Hill Victoria, Gurusamy Devikala, Zheng Zhili, Gartner Jared J, Prickett Todd D, Goff Stephanie L, Robbins Paul, Lu Yong-Chen, Rosenberg Steven A |
| 711396 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin |
2021-07-01 |
10.1136/jitc-2021-002707 |
Ylösmäki Erkko, Fusciello Manlio, Martins Beatriz, Feola Sara, Hamdan Firas, Chiaro Jacopo, Ylösmäki Leena, Vaughan Matthew J, Viitala Tapani, Kulkarni Prasad S, Cerullo Vincenzo |
| 711395 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study |
2021-07-01 |
10.1136/jitc-2021-002646 |
D'Angelo Sandra P, Lebbé Celeste, Mortier Laurent, Brohl Andrew S, Fazio Nicola, Grob Jean-Jacques, Prinzi Natalie, Hanna Glenn J, Hassel Jessica C, Kiecker Felix, Georges Sara, Ellers-Lenz Barbara, Shah Parantu, Güzel Gülseren, Nghiem Paul |
| 711394 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
CD11b+CTLA4+ myeloid cells are a key driver of tumor evasion in colorectal cancer |
2021-07-01 |
10.1136/jitc-2021-002841 |
Imazeki Hiroshi, Ogiwara Yamato, Kawamura Mami, Boku Narikazu, Kudo-Saito Chie |
| 711393 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Newly developed pseudogout arthritis after therapy with MAGE-A4 directed TCR T cells responded to treatment with tocilizumab |
2021-07-01 |
10.1136/jitc-2021-002716 |
Kim Sang T., Tayar Jean, Fu Siqing, Ke Danxia, Norry Elliot, Sun Amy, Miller Juli, Hong David S. |
| 711392 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockade |
2021-07-01 |
10.1136/jitc-2021-002428 |
Jeong Seongju, Park Eunyoung, Kim Hyung-Don, Sung Eunsil, Kim Hyunjoo, Jeon Jaehyoung, Kim Youngkwang, Jung Ui-jung, Son Yong-Gyu, Hong Youngeun, Lee Hanbyul, Lee Shinai, Lim Yangmi, Won Jonghwa, Jeon Minwoo, Hwang Shin, Fang Lei, Jiang Wenqing, Wang Zhengyi, Shin Eui-Cheol, Park Su-Hyung, Jung Jaeho |
| 711391 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells and construction of individualized TCR-engineered T cells for EBV-associated malignancies |
2021-07-01 |
10.1136/jitc-2021-002516 |
Zhang Chaoting, Tan Qin, Li Shance, Shen Luyan, Zhang Jingtao, Liu Ying, Yang Wenjun, Lu Zheming |
| 711390 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma |
2021-07-01 |
10.1136/jitc-2021-002703 |
Borch Troels Holz, Harbst Katja, Rana Aynal Haque, Andersen Rikke, Martinenaite Evelina, Kongsted Per, Pedersen Magnus, Nielsen Morten, Kjeldsen Julie Westerlin, Kverneland Anders Handrup, Lauss Martin, Hölmich Lisbet Rosenkrantz, Hendel Helle, Met Özcan, Jönsson Göran, Donia Marco, Marie Svane Inge |
| 711389 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data |
2021-07-01 |
10.1136/jitc-2021-002896 |
Reynolds Kerry L, Arora Shaily, Elayavilli Ravikumar Komandur, Louv William C, Schaller Teilo H, Khandelwal Aakanksha, Rothenberg Mace, Khozin Sean, Guidon Amanda C, Dougan Michael, Zubiri Leyre, Petrillo Laura, Sise Meghan E, Villani Alexandra-Chloe, Johnson Douglas B, Rahma Osama, Sharon Elad |
